» Articles » PMID: 27774019

Exacerbations in the Pre- and Post-COPD Diagnosis Periods

Overview
Journal Pragmat Obs Res
Publisher Dove Medical Press
Specialty General Medicine
Date 2013 Apr 30
PMID 27774019
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Chronic obstructive pulmonary disease (COPD) is usually recognized in its later stages, delaying therapeutic opportunities. Screening questionnaires have modest sensitivities and specificities. Adding questions about prior respiratory events might improve screening characteristics.

Methods: Using administrative data from all health care facilities in Olmsted County, Minnesota USA, we identified all adults with an initial diagnosis of COPD from 2005 through 2007. For each individual we identified all coded lower and upper respiratory events in the 2 years before and the 2 years after the COPD diagnosis and categorized them as probable or possible COPD exacerbations.

Results: 356 women and 346 men (N = 702) with a mean age of 67.5 years and 66.6 years respectively had a first diagnosis of COPD during the study period. Respiratory events in the 2 years prior to a COPD diagnosis were common with a range of 0 to 16 events per individual and a mean (SD) of 2.04 (2.14), 1.38 (1.86) all of which were probable COPD exacerbations. Prediagnostic respiratory events were predictive of similar events in the post diagnostic period (odds ratio = 1.6, 95% confidence interval [CI] 1.3 to 1.8).

Conclusion: Inquiring about the number and type of upper or lower respiratory events in the 2 past years may be a useful addition to the "screening" criteria to improve COPD identification, especially those at risk of frequent exacerbations.

Citing Articles

Risk of cardiovascular events after an exacerbation of chronic obstructive pulmonary disease: results from the EXACOS-CV cohort study using the PHARMO Data Network in the Netherlands.

Swart K, Baak B, Lemmens L, Penning-van Beest F, Bengtsson C, Lobier M Respir Res. 2023; 24(1):293.

PMID: 37990197 PMC: 10662240. DOI: 10.1186/s12931-023-02601-4.


Single Nucleotide Polymorphisms of Gene in Chronic Obstructive Pulmonary Disease-A Case Control Study in Vietnam.

Pham K, Tran N, Do Tran H, Ngo T, De Tran V, Ly H Adv Respir Med. 2023; 91(3):268-277.

PMID: 37366807 PMC: 10295170. DOI: 10.3390/arm91030021.


History of Respiratory Events Prior to a First COPD Diagnosis and Future Exacerbations: A Longitudinal Observational Cohort Database Study in Japan.

Ding B, Zaha R, Makita N, Graham S, Lambrelli D, Huse S Int J Chron Obstruct Pulmon Dis. 2023; 18:247-258.

PMID: 36915637 PMC: 10007995. DOI: 10.2147/COPD.S389297.


COPD - do the right thing.

Sandelowsky H, Weinreich U, Aarli B, Sundh J, Hoines K, Stratelis G BMC Fam Pract. 2021; 22(1):244.

PMID: 34895164 PMC: 8666021. DOI: 10.1186/s12875-021-01583-w.


Mechanisms, Pathophysiology and Currently Proposed Treatments of Chronic Obstructive Pulmonary Disease.

de Oliveira Rodrigues S, da Cunha C, Soares G, Silva P, Silva A, Goncalves-de-Albuquerque C Pharmaceuticals (Basel). 2021; 14(10).

PMID: 34681202 PMC: 8539950. DOI: 10.3390/ph14100979.


References
1.
Kotz D, Nelemans P, van Schayck C, Wesseling G . External validation of a COPD diagnostic questionnaire. Eur Respir J. 2007; 31(2):298-303. DOI: 10.1183/09031936.00074307. View

2.
St Sauver J, Grossardt B, Yawn B, Melton 3rd L, Rocca W . Use of a medical records linkage system to enumerate a dynamic population over time: the Rochester epidemiology project. Am J Epidemiol. 2011; 173(9):1059-68. PMC: 3105274. DOI: 10.1093/aje/kwq482. View

3.
Kurland L, Molgaard C . The patient record in epidemiology. Sci Am. 1981; 245(4):54-63. DOI: 10.1038/scientificamerican1081-54. View

4.
Yawn B, Mannino D, Littlejohn T, Ruoff G, Emmett A, Raphiou I . Prevalence of COPD among symptomatic patients in a primary care setting. Curr Med Res Opin. 2009; 25(11):2671-7. DOI: 10.1185/03007990903241350. View

5.
Yawn B, Keenan J . COPD--the primary care perspective: addressing epidemiology, pathology, diagnosis, treatment of smoking's multiple morbidities and the patient's perspective. COPD. 2007; 4(1):67-83. DOI: 10.1080/15412550601169562. View